The global Complement Drug for Blood Disease market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Complement Drug for Blood Disease companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Complement Drug for Blood Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Complement Drug for Blood Disease. This report contains market size and forecasts of Complement Drug for Blood Disease in global, including the following market information:
Global Complement Drug for Blood Disease market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Complement Drug for Blood Disease companies in 2024 (%)
Total Market by Segment:
Global Complement Drug for Blood Disease market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Complement Drug for Blood Disease market segment percentages, by Type, 2024 (%)
Peptides
Antibodies
Others
Global Complement Drug for Blood Disease market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Complement Drug for Blood Disease market segment percentages, by Application, 2024 (%)
Hospital
Clinic
Others
Global Complement Drug for Blood Disease market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Complement Drug for Blood Disease market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Complement Drug for Blood Disease revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Complement Drug for Blood Disease revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amyndas
Apellis
Novartis
Roche
Regeneron
Amgen
Samsung Bioepis
Alnylam
Akari Therapeutics
UCB
Outline of Major Chapters:
Chapter 1: Introduces the definition of Complement Drug for Blood Disease, market overview.
Chapter 2: Global Complement Drug for Blood Disease market size in revenue.
Chapter 3: Detailed analysis of Complement Drug for Blood Disease company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Complement Drug for Blood Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Complement Drug for Blood Disease Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Complement Drug for Blood Disease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Complement Drug for Blood Disease Overall Market Size
2.1 Global Complement Drug for Blood Disease Market Size: 2024 VS 2032
2.2 Global Complement Drug for Blood Disease Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Complement Drug for Blood Disease Players in Global Market
3.2 Top Global Complement Drug for Blood Disease Companies Ranked by Revenue
3.3 Global Complement Drug for Blood Disease Revenue by Companies
3.4 Top 3 and Top 5 Complement Drug for Blood Disease Companies in Global Market, by Revenue in 2024
3.5 Global Companies Complement Drug for Blood Disease Product Type
3.6 Tier 1, Tier 2, and Tier 3 Complement Drug for Blood Disease Players in Global Market
3.6.1 List of Global Tier 1 Complement Drug for Blood Disease Companies
3.6.2 List of Global Tier 2 and Tier 3 Complement Drug for Blood Disease Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Complement Drug for Blood Disease Market Size Markets, 2024 & 2032
4.1.2 Peptides
4.1.3 Antibodies
4.1.4 Others
4.2 Segmentation by Type - Global Complement Drug for Blood Disease Revenue & Forecasts
4.2.1 Segmentation by Type - Global Complement Drug for Blood Disease Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Complement Drug for Blood Disease Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Complement Drug for Blood Disease Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Complement Drug for Blood Disease Market Size, 2024 & 2032
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 Segmentation by Application - Global Complement Drug for Blood Disease Revenue & Forecasts
5.2.1 Segmentation by Application - Global Complement Drug for Blood Disease Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Complement Drug for Blood Disease Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Complement Drug for Blood Disease Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Complement Drug for Blood Disease Market Size, 2024 & 2032
6.2 By Region - Global Complement Drug for Blood Disease Revenue & Forecasts
6.2.1 By Region - Global Complement Drug for Blood Disease Revenue, 2020-2025
6.2.2 By Region - Global Complement Drug for Blood Disease Revenue, 2026-2032
6.2.3 By Region - Global Complement Drug for Blood Disease Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Complement Drug for Blood Disease Revenue, 2020-2032
6.3.2 United States Complement Drug for Blood Disease Market Size, 2020-2032
6.3.3 Canada Complement Drug for Blood Disease Market Size, 2020-2032
6.3.4 Mexico Complement Drug for Blood Disease Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Complement Drug for Blood Disease Revenue, 2020-2032
6.4.2 Germany Complement Drug for Blood Disease Market Size, 2020-2032
6.4.3 France Complement Drug for Blood Disease Market Size, 2020-2032
6.4.4 U.K. Complement Drug for Blood Disease Market Size, 2020-2032
6.4.5 Italy Complement Drug for Blood Disease Market Size, 2020-2032
6.4.6 Russia Complement Drug for Blood Disease Market Size, 2020-2032
6.4.7 Nordic Countries Complement Drug for Blood Disease Market Size, 2020-2032
6.4.8 Benelux Complement Drug for Blood Disease Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Complement Drug for Blood Disease Revenue, 2020-2032
6.5.2 China Complement Drug for Blood Disease Market Size, 2020-2032
6.5.3 Japan Complement Drug for Blood Disease Market Size, 2020-2032
6.5.4 South Korea Complement Drug for Blood Disease Market Size, 2020-2032
6.5.5 Southeast Asia Complement Drug for Blood Disease Market Size, 2020-2032
6.5.6 India Complement Drug for Blood Disease Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Complement Drug for Blood Disease Revenue, 2020-2032
6.6.2 Brazil Complement Drug for Blood Disease Market Size, 2020-2032
6.6.3 Argentina Complement Drug for Blood Disease Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Complement Drug for Blood Disease Revenue, 2020-2032
6.7.2 Turkey Complement Drug for Blood Disease Market Size, 2020-2032
6.7.3 Israel Complement Drug for Blood Disease Market Size, 2020-2032
6.7.4 Saudi Arabia Complement Drug for Blood Disease Market Size, 2020-2032
6.7.5 UAE Complement Drug for Blood Disease Market Size, 2020-2032
7 Companies Profiles
7.1 Amyndas
7.1.1 Amyndas Corporate Summary
7.1.2 Amyndas Business Overview
7.1.3 Amyndas Complement Drug for Blood Disease Major Product Offerings
7.1.4 Amyndas Complement Drug for Blood Disease Revenue in Global Market (2020-2025)
7.1.5 Amyndas Key News & Latest Developments
7.2 Apellis
7.2.1 Apellis Corporate Summary
7.2.2 Apellis Business Overview
7.2.3 Apellis Complement Drug for Blood Disease Major Product Offerings
7.2.4 Apellis Complement Drug for Blood Disease Revenue in Global Market (2020-2025)
7.2.5 Apellis Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Complement Drug for Blood Disease Major Product Offerings
7.3.4 Novartis Complement Drug for Blood Disease Revenue in Global Market (2020-2025)
7.3.5 Novartis Key News & Latest Developments
7.4 Roche
7.4.1 Roche Corporate Summary
7.4.2 Roche Business Overview
7.4.3 Roche Complement Drug for Blood Disease Major Product Offerings
7.4.4 Roche Complement Drug for Blood Disease Revenue in Global Market (2020-2025)
7.4.5 Roche Key News & Latest Developments
7.5 Regeneron
7.5.1 Regeneron Corporate Summary
7.5.2 Regeneron Business Overview
7.5.3 Regeneron Complement Drug for Blood Disease Major Product Offerings
7.5.4 Regeneron Complement Drug for Blood Disease Revenue in Global Market (2020-2025)
7.5.5 Regeneron Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Complement Drug for Blood Disease Major Product Offerings
7.6.4 Amgen Complement Drug for Blood Disease Revenue in Global Market (2020-2025)
7.6.5 Amgen Key News & Latest Developments
7.7 Samsung Bioepis
7.7.1 Samsung Bioepis Corporate Summary
7.7.2 Samsung Bioepis Business Overview
7.7.3 Samsung Bioepis Complement Drug for Blood Disease Major Product Offerings
7.7.4 Samsung Bioepis Complement Drug for Blood Disease Revenue in Global Market (2020-2025)
7.7.5 Samsung Bioepis Key News & Latest Developments
7.8 Alnylam
7.8.1 Alnylam Corporate Summary
7.8.2 Alnylam Business Overview
7.8.3 Alnylam Complement Drug for Blood Disease Major Product Offerings
7.8.4 Alnylam Complement Drug for Blood Disease Revenue in Global Market (2020-2025)
7.8.5 Alnylam Key News & Latest Developments
7.9 Akari Therapeutics
7.9.1 Akari Therapeutics Corporate Summary
7.9.2 Akari Therapeutics Business Overview
7.9.3 Akari Therapeutics Complement Drug for Blood Disease Major Product Offerings
7.9.4 Akari Therapeutics Complement Drug for Blood Disease Revenue in Global Market (2020-2025)
7.9.5 Akari Therapeutics Key News & Latest Developments
7.10 UCB
7.10.1 UCB Corporate Summary
7.10.2 UCB Business Overview
7.10.3 UCB Complement Drug for Blood Disease Major Product Offerings
7.10.4 UCB Complement Drug for Blood Disease Revenue in Global Market (2020-2025)
7.10.5 UCB Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Complement Drug for Blood Disease Market Opportunities & Trends in Global Market
Table 2. Complement Drug for Blood Disease Market Drivers in Global Market
Table 3. Complement Drug for Blood Disease Market Restraints in Global Market
Table 4. Key Players of Complement Drug for Blood Disease in Global Market
Table 5. Top Complement Drug for Blood Disease Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Complement Drug for Blood Disease Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Complement Drug for Blood Disease Revenue Share by Companies, 2020-2025
Table 8. Global Companies Complement Drug for Blood Disease Product Type
Table 9. List of Global Tier 1 Complement Drug for Blood Disease Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Complement Drug for Blood Disease Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Complement Drug for Blood Disease Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Complement Drug for Blood Disease Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Complement Drug for Blood Disease Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Complement Drug for Blood Disease Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Complement Drug for Blood Disease Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Complement Drug for Blood Disease Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Complement Drug for Blood Disease Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Complement Drug for Blood Disease Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Complement Drug for Blood Disease Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Complement Drug for Blood Disease Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Complement Drug for Blood Disease Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Complement Drug for Blood Disease Revenue, (US$, Mn), 2026-2032
Table 30. Amyndas Corporate Summary
Table 31. Amyndas Complement Drug for Blood Disease Product Offerings
Table 32. Amyndas Complement Drug for Blood Disease Revenue (US$, Mn) & (2020-2025)
Table 33. Amyndas Key News & Latest Developments
Table 34. Apellis Corporate Summary
Table 35. Apellis Complement Drug for Blood Disease Product Offerings
Table 36. Apellis Complement Drug for Blood Disease Revenue (US$, Mn) & (2020-2025)
Table 37. Apellis Key News & Latest Developments
Table 38. Novartis Corporate Summary
Table 39. Novartis Complement Drug for Blood Disease Product Offerings
Table 40. Novartis Complement Drug for Blood Disease Revenue (US$, Mn) & (2020-2025)
Table 41. Novartis Key News & Latest Developments
Table 42. Roche Corporate Summary
Table 43. Roche Complement Drug for Blood Disease Product Offerings
Table 44. Roche Complement Drug for Blood Disease Revenue (US$, Mn) & (2020-2025)
Table 45. Roche Key News & Latest Developments
Table 46. Regeneron Corporate Summary
Table 47. Regeneron Complement Drug for Blood Disease Product Offerings
Table 48. Regeneron Complement Drug for Blood Disease Revenue (US$, Mn) & (2020-2025)
Table 49. Regeneron Key News & Latest Developments
Table 50. Amgen Corporate Summary
Table 51. Amgen Complement Drug for Blood Disease Product Offerings
Table 52. Amgen Complement Drug for Blood Disease Revenue (US$, Mn) & (2020-2025)
Table 53. Amgen Key News & Latest Developments
Table 54. Samsung Bioepis Corporate Summary
Table 55. Samsung Bioepis Complement Drug for Blood Disease Product Offerings
Table 56. Samsung Bioepis Complement Drug for Blood Disease Revenue (US$, Mn) & (2020-2025)
Table 57. Samsung Bioepis Key News & Latest Developments
Table 58. Alnylam Corporate Summary
Table 59. Alnylam Complement Drug for Blood Disease Product Offerings
Table 60. Alnylam Complement Drug for Blood Disease Revenue (US$, Mn) & (2020-2025)
Table 61. Alnylam Key News & Latest Developments
Table 62. Akari Therapeutics Corporate Summary
Table 63. Akari Therapeutics Complement Drug for Blood Disease Product Offerings
Table 64. Akari Therapeutics Complement Drug for Blood Disease Revenue (US$, Mn) & (2020-2025)
Table 65. Akari Therapeutics Key News & Latest Developments
Table 66. UCB Corporate Summary
Table 67. UCB Complement Drug for Blood Disease Product Offerings
Table 68. UCB Complement Drug for Blood Disease Revenue (US$, Mn) & (2020-2025)
Table 69. UCB Key News & Latest Developments
List of Figures
Figure 1. Complement Drug for Blood Disease Product Picture
Figure 2. Complement Drug for Blood Disease Segment by Type in 2024
Figure 3. Complement Drug for Blood Disease Segment by Application in 2024
Figure 4. Global Complement Drug for Blood Disease Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Complement Drug for Blood Disease Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Complement Drug for Blood Disease Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Complement Drug for Blood Disease Revenue in 2024
Figure 9. Segmentation by Type � Global Complement Drug for Blood Disease Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Complement Drug for Blood Disease Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Complement Drug for Blood Disease Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Complement Drug for Blood Disease Revenue Market Share, 2020-2032
Figure 13. By Region - Global Complement Drug for Blood Disease Revenue Market Share, 2020-2032
Figure 14. By Country - North America Complement Drug for Blood Disease Revenue Market Share, 2020-2032
Figure 15. United States Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Complement Drug for Blood Disease Revenue Market Share, 2020-2032
Figure 19. Germany Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 20. France Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Complement Drug for Blood Disease Revenue Market Share, 2020-2032
Figure 27. China Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 31. India Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Complement Drug for Blood Disease Revenue Market Share, 2020-2032
Figure 33. Brazil Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Complement Drug for Blood Disease Revenue Market Share, 2020-2032
Figure 36. Turkey Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Complement Drug for Blood Disease Revenue, (US$, Mn), 2020-2032
Figure 40. Amyndas Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Apellis Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Novartis Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Roche Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Regeneron Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Amgen Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Samsung Bioepis Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Alnylam Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Akari Therapeutics Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. UCB Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
